Neuland Laboratories on Thursday informed the exchanges that the United States Food and Drug Administration inspected one of its manufacturing facilities (unit 2) at Pashmylaram, Patancheru, Sangareddy district, Telangana, on November 26-28. The inspection was completed successfully with no observations under Form 483, the company said. Shares of Neuland Laboratories jumped 5.65 per cent at ₹517.20 on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.